Replies to post #42101 on OncoSec Medical Inc (ONCSQ)

[lasers]

Yes most definitely. $ONCS EP+IL12 induces autologous TCells and more IL12s gneration inside the hot tumors converted from being a cold tumors and hence the 57% BORR rate going on +18 months with the Keytruda Combo. IMO Dan's job is much easier than the ADXS case

[dr_lowenstein]

I think you mean Advaxis. When I do diligence on a company I find it important to get all the facts right, such as company name. As for Incyte, give us a break, sure Incyte is shaking in their boots